Literature DB >> 26696540

Expression of PD-1/LAG-3 and cytokine production by CD4(+) T cells during infection with Plasmodium parasites.

Henrietta T Doe1, Daisuke Kimura1, Mana Miyakoda1, Kazumi Kimura1, Masoud Akbari1, Katsuyuki Yui1.   

Abstract

CD4(+) T cells play critical roles in protection against the blood stage of malarial infection; however, their uncontrolled activation can be harmful to the host. In this study, in which rodent models of Plasmodium parasites were used, the expression of inhibitory receptors on activated CD4(+) T cells and their cytokine production was compared with their expression in a bacterial and another protozoan infection. CD4(+) T cells from mice infected with P. yoelii 17XL, P yoelii 17XNL, P. chabaudi, P. vinckei and P. berghei expressed the inhibitory receptors, PD-1 and LAG-3, as early as 6 days after infection, whereas those from either Listeria monocytogenes- or Leishmania major-infected mice did not. In response to T-cell receptor stimulation, CD4(+) T cells from mice infected with all the pathogens under study produced high concentrations of IFN-γ. IL-2 production was reduced in mice infected with Plasmodium species, but not in those infected with Listeria or Leishmania. In vitro blockade of the interaction between PD-1 and its ligands resulted in increased IFN-γ production in response to Plasmodium antigens, implying that PD-1 expressed on activated CD4(+) T cells actively inhibits T cell immune responses. Studies using Myd88(-/-), Trif(-/-) and Irf3(-/-) mice showed that induction of these CD4(+) T cells and their ability to produce cytokines is largely independent of TLR signaling. These studies suggest that expression of the inhibitory receptors PD-1 and LAG-3 on CD4(+) T cells and their reduced IL-2 production are common characteristic features of Plasmodium infection.
© 2015 The Societies and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  CD4+ T cells; cytokines; inhibitory receptor; malaria

Mesh:

Substances:

Year:  2016        PMID: 26696540     DOI: 10.1111/1348-0421.12354

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  11 in total

1.  Deciphering the Plasmodium falciparum malaria-specific CD4+ T-cell response: ex vivo detection of high frequencies of PD-1+TIGIT+ EXP1-specific CD4+ T cells using a novel HLA-DR11-restricted MHC class II tetramer.

Authors:  Sophia Schulte; Janna Heide; Christin Ackermann; Sven Peine; Michael Ramharter; Maria Sophia Mackroth; Robin Woost; Thomas Jacobs; Julian Schulze Zur Wiesch
Journal:  Clin Exp Immunol       Date:  2022-04-04       Impact factor: 4.330

Review 2.  Recent advances on T-cell exhaustion in malaria infection.

Authors:  Esaki M Shankar; R Vignesh; A P Dash
Journal:  Med Microbiol Immunol       Date:  2018-06-23       Impact factor: 3.402

Review 3.  Modulation of Innate Immune Mechanisms to Enhance Leishmania Vaccine-Induced Immunity: Role of Coinhibitory Molecules.

Authors:  Sreenivas Gannavaram; Parna Bhattacharya; Nevien Ismail; Amit Kaul; Rakesh Singh; Hira L Nakhasi
Journal:  Front Immunol       Date:  2016-05-13       Impact factor: 7.561

4.  Immune Checkpoints in Leprosy: Immunotherapy As a Feasible Approach to Control Disease Progression.

Authors:  Hayana Ramos Lima; Thaís Helena Gasparoto; Tatiana Salles de Souza Malaspina; Vinícius Rizzo Marques; Marina Jurado Vicente; Elaine Camarinha Marcos; Fabiana Corvolo Souza; Maria Renata Sales Nogueira; Jaison Antônio Barreto; Gustavo Pompermaier Garlet; João Santana da Silva; Vânia Nieto Brito-de-Souza; Ana Paula Campanelli
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

5.  Different Expression Characteristics of LAG3 and PD-1 in Sepsis and Their Synergistic Effect on T Cell Exhaustion: A New Strategy for Immune Checkpoint Blockade.

Authors:  Bailin Niu; Fachun Zhou; Yanxin Su; Long Wang; Yuanyuan Xu; Ziying Yi; Yushen Wu; Huimin Du; Guosheng Ren
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 7.561

Review 6.  Cutting-Edge: Preclinical and Clinical Development of the First Approved Lag-3 Inhibitor.

Authors:  Luisa Chocarro; Ana Bocanegra; Ester Blanco; Leticia Fernández-Rubio; Hugo Arasanz; Miriam Echaide; Maider Garnica; Pablo Ramos; Sergio Piñeiro-Hermida; Ruth Vera; David Escors; Grazyna Kochan
Journal:  Cells       Date:  2022-07-30       Impact factor: 7.666

Review 7.  Understanding LAG-3 Signaling.

Authors:  Luisa Chocarro; Ester Blanco; Miren Zuazo; Hugo Arasanz; Ana Bocanegra; Leticia Fernández-Rubio; Pilar Morente; Gonzalo Fernández-Hinojal; Miriam Echaide; Maider Garnica; Pablo Ramos; Ruth Vera; Grazyna Kochan; David Escors
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

8.  Activation, Impaired Tumor Necrosis Factor-α Production, and Deficiency of Circulating Mucosal-Associated Invariant T Cells in Patients with Scrub Typhus.

Authors:  Seung-Ji Kang; Hye-Mi Jin; Eun Jeong Won; Young-Nan Cho; Hyun-Ju Jung; Yong-Soo Kwon; Hae Jin Kee; Jae Kyun Ju; Jung-Chul Kim; Uh Jin Kim; Hee-Chang Jang; Sook-In Jung; Seung-Jung Kee; Yong-Wook Park
Journal:  PLoS Negl Trop Dis       Date:  2016-07-27

9.  Inducible Costimulator Expressing T Cells Promote Parasitic Growth During Blood Stage Plasmodium berghei ANKA Infection.

Authors:  Gajendra M Jogdand; Soumya Sengupta; Gargee Bhattacharya; Santosh Kumar Singh; Prakash Kumar Barik; Satish Devadas
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561

10.  Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Plasmodium falciparum Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease.

Authors:  Marissa Herrmann; Sophia Schulte; Nils H Wildner; Melanie Wittner; Thomas Theo Brehm; Michael Ramharter; Robin Woost; Ansgar W Lohse; Thomas Jacobs; Julian Schulze Zur Wiesch
Journal:  Front Immunol       Date:  2020-08-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.